Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

08 juil. 2020 18h13 HE | Source: Bionano Genomics

First Extensive Validation Study of Saphyr for Constitutional Genetic Disorders by European Consortium Shows 100% Concordance to Standard Cytogenetics and Describes Resolution of Cases of Long-Standing, Undiagnosed Disease

First large study in constitutional genetic diseases showed 100% concordance to gold-standard cytogenetic testingIn patients with leukemia, Saphyr enabled crucial discoveries including novel fusion...
26 juin 2020 08h00 HE | Source: Bionano Genomics

The UK NHS, the Medical College of Wisconsin, and the Leading South Korean Yonsei University Hospital are Among Newest Adopters of Bionano Saphyr® for Digital Cytogenetic Applications

SAN DIEGO, June 26, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that King’s College Hospital London, part of the NHS (National Health Service) in the UK, the...
18 juin 2020 16h01 HE | Source: Bionano Genomics

Bionano Genomics Reports First Quarter 2020 Financial Results and Provides Business Update

SAN DIEGO, June 18, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and...
18 juin 2020 08h00 HE | Source: Bionano Genomics

Bionano Announces Amendment to Proxy Statement for Annual Meeting of Stockholders

SAN DIEGO, June 18, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that on June 17, 2020 it filed an amendment to its Proxy Statement for its 2020 Annual Meeting of...
12 juin 2020 08h46 HE | Source: Bionano Genomics

Bionano Genomics to Report First Quarter 2020 Financial Results and Host a Conference Call and Webcast on June 18

SAN DIEGO, June 12, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and...
11 juin 2020 08h00 HE | Source: Bionano Genomics

Data Presented at European Society of Human Genetics (ESHG) Conference Shows Saphyr System has 100% Concordance with Standard Cytogenetics in Leukemias and Constitutional Aberrations

ESHG Speaker Calls Bionano Data “a Cytogenetics Revolution” Multiple presentations at the European Society of Human Genetics show 100% concordance to gold-standard cytogenetic testingSaphyr...
08 juin 2020 08h00 HE | Source: Bionano Genomics

Bionano Genomics Announces Issuance of US Patent for Combined Nanochannel-Nanopore Device

SAN DIEGO, June 08, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that the United States Patent and Trademark Office will issue US Patent No. 10,676,352 on June 9th,...
27 mai 2020 08h00 HE | Source: Bionano Genomics

Bionano to Participate in Maxim Group’s Covid-19 Virtual Conference Series: The Role of Cell Therapy and Clarity on Testing

SAN DIEGO, May 27, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that Erik Holmlin, Ph.D., CEO of Bionano, will participate on a panel entitled: “Testing and...
19 mai 2020 08h00 HE | Source: Bionano Genomics

Cancer Genomics Consortium Members Demonstrate 100% Concordance Between Bionano Saphyr and Gold Standard Cytogenetics in Leukemia

SAN DIEGO, May 19, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) announced that in an online presentation hosted by the Cancer Genomics Consortium (CGC) on May 12, 2020, Dr. Brynn...
14 mai 2020 16h30 HE | Source: Bionano Genomics

Bionano Genomics to Report First Quarter 2020 Financial Results on June 18, 2020

SAN DIEGO, May 14, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and...

Page précédente

Page suivante